When the Lustgarten Foundation was established, pancreatic cancer was considered an orphan disease with very little money going into research and virtually no long-term treatment options. Lustgarten changed all that. Today, there are thousands of researchers working to improve patient outcomes and to discover breakthroughs in pancreatic cancer treatments. With us this morning to talk more about Lustgarten and the work they are doing for people with pancreatic cancer is Linda Tantawi, the CEO of the organization.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
